标题/作者 | 年份 |
---|---|
A Huang, H Zheng, Z Wu, M Chen, Y Huang Theranostics 10 (8), 3503 | 2020 |
B Li, L Zhu, C Lu, C Wang, H Wang, H Jin, X Ma, Z Cheng, C Yu, S Wang, ... Nature communications 12 (1), 295 | 2021 |
LS Kristensen, T Jakobsen, H Hager, J Kjems Nature reviews Clinical oncology 19 (3), 188-206 | 2022 |
MS Xiao, Y Ai, JE Wilusz Trends in cell biology 30 (3), 226-240 | 2020 |
L Chen, C Wang, H Sun, J Wang, Y Liang, Y Wang, G Wong Briefings in bioinformatics 22 (2), 1706-1728 | 2021 |
Z Liu, T Wang, Y She, K Wu, S Gu, L Li, C Dong, C Chen, Y Zhou Molecular Cancer 20, 1-25 | 2021 |
Y Wang, Z Wei, K Pan, J Li, Q Chen Apoptosis 25, 786-798 | 2020 |
Y Kong, Y Li, Y Luo, J Zhu, H Zheng, B Gao, X Guo, Z Li, R Chen, C Chen Molecular Cancer 19, 1-17 | 2020 |
S Shen, T Yao, Y Xu, D Zhang, S Fan, J Ma Molecular cancer 19, 1-17 | 2020 |
X Yang, T Ye, H Liu, P Lv, C Duan, X Wu, K Jiang, H Lu, D Xia, E Peng, ... Molecular cancer 20 (1), 1-25 | 2021 |
Z Feng, L Zhang, S Wang, Q Hong Biochemical and biophysical research communications 522 (2), 388-394 | 2020 |
W Gao, H Guo, M Niu, X Zheng, Y Zhang, X Xue, Y Bo, X Guan, Z Li, ... Molecular cancer 19, 1-22 | 2020 |
X Liu, X Wang, J Li, S Hu, Y Deng, H Yin, X Bao, QC Zhang, G Wang, ... Science China Life sciences 63, 1429-1449 | 2020 |
S Ma, S Kong, F Wang, S Ju Molecular cancer 19, 1-19 | 2020 |
S Mirzaei, MH Gholami, K Hushmandi, F Hashemi, A Zabolian, I Canadas, ... Journal of Hematology & Oncology 15 (1), 18 | 2022 |
Y Li, Y Ge, L Xu, R Jia Life sciences 254, 117176 | 2020 |
CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis F Zheng, R Xu Biomedicine & Pharmacotherapy 124, 109828 | 2020 |
S Gong, F Gaccioli, J Dopierala, U Sovio, E Cook, PJ Volders, L Martens, ... Nature Communications 12 (1), 2639 | 2021 |
W Li, FQ Yang, CM Sun, JH Huang, HM Zhang, X Li, GC Wang, N Zhang, ... Theranostics 10 (10), 4395 | 2020 |
C Wang, S Tan, J Li, WR Liu, Y Peng, W Li Cancer letters 492, 106-115 | 2020 |
1 - 20
计算机程序会自动估算并确定日期和引用次数。